Inventor · disambiguated record
Mehdi Mesri
Also filed as: MESRI MEHDI
7 granted patents·6 pending applications·71 citations·filing 2003–2020
84Inventor score
Top patents by PatentIndex Score
13 records- 0192US7842291B1Methods and compositions for diagnosing and treating diseasesCELERA CORP·Filed 2007·Granted Nov 30, 2010·14 cites·4 claims
- 0291US7892760B2Lung cancer markers, and uses thereofCELERA CORP·Filed 2008·Granted Feb 22, 2011·16 cites·39 claims
- 0389US11105806B2Lung cancer markers and uses thereofCELERA CORP·Filed 2019·Granted Aug 31, 2021·2 cites·31 claims
- 0487US8067544B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2004·Granted Nov 29, 2011·37 cites·18 claims
- 0581US10338075B2Lung cancer markers and uses thereofCELERA CORP·Filed 2016·Granted Jul 2, 2019·2 cites·35 claims
- 0670US2020276329A1Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2020·Application pending·0 cites
- 0766US2017350897A1Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2017·Application pending·0 cites
- 0862US2015037820A1Lung cancer markers and uses thereofCELERA CORP·Filed 2014·Application pending·0 cites
- 0950US8808997B2Lung cancer markers, and uses thereofBIRSE CHARLES·Filed 2011·Granted Aug 19, 2014·0 cites·38 claims
- 1050US2017218067A1Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses ThereofCELLDEX THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1149US9580503B2Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereofLANDES GREGORY M·Filed 2011·Granted Feb 28, 2017·0 cites·16 claims
- 1237US2005014687A1Therapeutic polypeptides, nucleic acids encoding same, and methods of useFiled 2003·Application pending·0 cites
- 1336US2005197292A1Compositions and methods for treating T-cell mediated pathological conditionsFiled 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →